Skip to main content
. Author manuscript; available in PMC: 2014 Aug 28.
Published in final edited form as: J Am Chem Soc. 2013 Aug 15;135(34):12707–12721. doi: 10.1021/ja4049493

Table 2.

Biodistribution data of 111In/177Lu-H4octapa-trastuzumab and 111In/177Lu-DOTA-trastuzumab. Performed over a 5 day period in mice bearing SKOV-3 ovarian cancer xenografts, tumor volume ~ 100–150 mm3 (n = 4 for each time point).

111In-octapa-trastuzumab 111In-DOTA-trastuzumab
Organ 24 h 48 h 72 h 96 h 120 h Organ 24 h 48 h 72 h 96 h 120 h
Blood 6.9 ± 5.1 7.6 ± 6.5 10.5 ± 7.1 6.9 ± 6.6 11.4 ± 6 Blood 18 ± 1.7 17.3 ± 2.6 16.8 ± 2.2 15 ± 3.6 14.3 ± 1.6
Tumor 57.4 ± 22 58.3 ± 17.2 57.8 ± 14.6 68.7 ± 20.5 72.4 ± 21.3 Tumor 22.3 ± 6.4 28.4 ± 5.2 30.6 ± 9.1 32.8 ± 7.3 31.5 ± 3.8
Heart 2.6 ± 0.5 2.5 ± 1.5 2.7 ± 1.4 1.9 ± 1.4 3.6 ± 1.6 Heart 6.1 ± 0.9 6.6 ± 2 5.6 ± 1.3 5.2 ± 1.8 5.2 ± 0.9
Lungs 4.4 ± 2.1 3.9 ± 2.3 5 ± 2.8 3.8 ± 3.3 6.3 ± 3 Lungs 7.2 ± 1.6 6.8 ± 3.3 5.2 ± 1.4 6.3 ± 1.2 5.7 ± 2.2
Liver 12 ± 2.4 10.6 ± 1.2 9.1 ± 0.8 8.5 ± 2 6.6 ± 0.6 Liver 6.2 ± 0.4 5.5 ± 1.4 4.8 ± 1.3 4.4 ± 1.7 5.2 ± 1.2
Spleen 8.9 ± 2.4 7.6 ± 1 8.1 ± 0.8 7.4 ± 1.1 6.5 ± 1.6 Spleen 3.6 ± 0.8 3.7 ± 1.6 3 ± 0.7 2.7 ± 0.7 3.4 ± 1.4
Stomach 1.4 ± 0.2 0.8 ± 0.2 1.2 ± 0.1 0.7 ± 0.3 0.7 ± 0.2 Stomach 0.7 ± 0.1 0.7 ± 0.4 0.8 ± 0.2 0.3 ± 0.2 0.6 ± 0.3
Lg Intestine 3.7 ± 0.4 2.5 ± 0.7 2 ± 0.9 1.7 ± 0.4 1.2 ± 0.1 Lg Intestine 0.5 ± 0.1 0.6 ± 0.1 0.7 ± 0.1 0.5 ± 0.1 0.5 ± 0.1
Sm Intestine 3.8 ± 0.7 2.1 ± 0.4 2.5 ± 0.6 2.1 ± 0.4 1.5 ± 0.1 Sm Intestine 1.9 ± 0.1 1.6 ± 0.5 1.7 ± 0.1 1.1 ± 0.2 1.3 ± 0.1
Kidney 3.6 ± 1.2 4.2 ± 2.1 4.3 ± 2.1 3.5 ± 2 4.3 ± 1.6 Kidney 5.3 ± 0.5 6.3 ± 0.9 5.1 ± 1.7 5.8 ± 1.7 4.9 ± 0.4
Muscle 1.3 ± 0.5 0.9 ± 0.5 1 ± 0.5 0.8 ± 0.5 0.9 ± 0.5 Muscle 0.7 ± 0.2 0.8 ± 0.3 0.5 ± 0.1 0.4 ± 0.1 0.3 ± 0.1
Bone 4.1 ± 2 3.5 ± 0.4 2.8 ± 1 3.3 ± 0.5 1.4 ± 0.3 Bone 1 ± 0.3 0.9 ± 0.1 1.1 ± 0.4 0.9 ± 0.4 0.6 ± 0.2
Skin 10.8 ± 1.4 9.3 ± 1.4 7.2 ± 2.1 5.4 ± 1.2 3 ± 1.1 Skin 1.8 ± 0.4 2.1 ± 0.7 2.6 ± 0.1 1.7 ± 0.8 2.2 ± 0.8

177Lu-octapa-trastuzumab 177Lu-DOTA-trastuzumab
Organ 24 h 48 h 72 h 96 h 120 h Organ 24 h 48 h 72 h 96 h 120 h

Blood 19.1 ± 1.5 9.1 ± 9.5 9.7 ± 5.2 8.9 ± 6.9 7.6 ± 5.7 Blood 20.4 ± 1.7 17.4 ± 1 18.1 ± 2.8 15 ± 0.8 14.7 ± 0.7
Tumor 50 ± 5.4 63.5 ± 15 62.4 ± 20 70.4 ± 25.8 56.6 ± 12.7 Tumor 18.3 ± 4.8 31.6 ± 2.9 32.1 ± 7.4 37 ± 9.5 37.4 ± 10.3
Heart 4.2 ± 0.7 3.2 ± 1.9 2.5 ± 0.9 2.3 ± 0.7 2.6 ± 1.4 Heart 7.2 ± 1 4.9 ± 3.3 5.8 ± 1.6 4.6 ± 1.1 5.4 ± 0.6
Lung 7.8 ± 3.6 3.9 ± 3.1 5 ± 2.3 4.4 ± 2.5 2.7 ± 1.8 Lungs 10 ± 1.5 6.7 ± 4.6 7.1 ± 2.3 6.3 ± 0.6 6 ± 2.1
Liver 10.1 ± 1.3 13.2 ± 4 9.5 ± 3.5 9.8 ± 1.7 8 ± 2.6 Liver 4.5 ± 2 5.7 ± 3.6 5.7 ± 2.5 2.8 ± 0.9 3.7 ± 1.9
Spleen 8.8 ± 2.3 11.5 ± 2.5 7.4 ± 2.8 9.2 ± 1.2 6.7 ± 2.4 Spleen 3.8 ± 0.5 3.1 ± 2.9 3.2 ± 1 3.5 ± 0.4 3.8 ± 1
Stomach 1.4 ± 0.3 1 ± 0.5 0.9 ± 0.4 1.1 ± 0.3 0.6 ± 0.2 Stomach 0.7 ± 0.2 1.3 ± 1.9 0.9 ± 0.2 0.8 ± 0.2 0.7 ± 0.2
Lg Intestine 1.3 ± 0.3 1 ± 0.3 1.1 ± 0.5 1.1 ± 0.2 0.8 ± 0.2 Lg Intestine 0.6 ± 0.1 0.5 ± 0.3 0.8 ± 0.2 0.5 ± 0.1 0.6 ± 0.2
Sm Intestine 1.9 ± 0.5 2.5 ± 1.1 2 ± 0.9 2.3 ± 0.4 1.6 ± 0.4 Sm Intestine 1.7 ± 0.2 1.5 ± 1 1.5 ± 0.4 1.4 ± 0.3 1.2 ± 0.1
Kidney 4.9 ± 0.9 3.8 ± 2 3.7 ± 1.2 3.8 ± 1.8 2.8 ± 1.2 Kidney 5.5 ± 1.7 7.3 ± 0.7 5.1 ± 0.8 4.4 ± 0.2 7.1 ± 5
Muscle 0.9 ± 0.2 0.7 ± 0.5 0.8 ± 0.5 0.5 ± 0.2 0.4 ± 0.2 Muscle 0.7 ± 0.2 0.5 ± 0.4 0.4 ± 0.1 0.5 ± 0.2 0.5 ± 0.1
Bone 3.2 ± 0.5 4 ± 0.6 3.1 ± 0.7 4.2 ± 1.5 3.6 ± 1.7 Bone 1.2 ± 0 1.3 ± 0.8 1.3 ± 0.3 0.9 ± 0.2 1.4 ± 0.3
Skin 8.4 ± 2 6.8 ± 2.9 6.9 ± 0.5 5.6 ± 1.2 4.1 ± 2.2 Skin 1.9 ± 0.9 2.4 ± 1.7 2.1 ± 0.2 2.1 ± 0.7 3.1 ± 1.3